Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens

被引:1554
作者
Zheng, Yan [1 ]
Valdez, Patricia A. [1 ]
Danilenko, Dimitry M. [2 ]
Hu, Yan [1 ]
Sa, Susan M. [2 ]
Gong, Qian [1 ]
Abbas, Alexander R. [3 ]
Modrusan, Zora [4 ]
Ghilardi, Nico [4 ]
de Sauvage, Frederic J. [4 ]
Ouyang, Wenjun [1 ]
机构
[1] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA
[3] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA
[4] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA
关键词
D O I
10.1038/nm1720
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Infections by attaching and effacing (A/E) bacterial pathogens, such as Escherichia coli O157:H7, pose a serious threat to public health. Using a mouse A/E pathogen, Citrobacter rodentium, we show that interleukin-22 (IL-22) has a crucial role in the early phase of host defense against C. rodentium. Infection of IL-22 knockout mice results in increased intestinal epithelial damage, systemic bacterial burden and mortality. We also find that IL-23 is required for the early induction of IL-22 during C. rodentium infection, and adaptive immunity is not essential for the protective role of IL-22 in this model. Instead, IL-22 is required for the direct induction of the Reg family of antimicrobial proteins, including RegIII beta and RegIII gamma, in colonic epithelial cells. Exogenous mouse or human RegIII gamma substantially improves survival of IL-22 knockout mice after C. rodentium infection. Together, our data identify a new innate immune function for IL-22 in regulating early defense mechanisms against A/E bacterial pathogens.
引用
收藏
页码:282 / 289
页数:8
相关论文
共 44 条
[11]   Critical role for tumor necrosis factor alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis [J].
Gonçalves, NS ;
Ghaem-Maghami, M ;
Monteleone, G ;
Frankel, G ;
Dougan, G ;
Lewis, DJM ;
Simmons, CP ;
MacDonald, TT .
INFECTION AND IMMUNITY, 2001, 69 (11) :6651-6659
[12]   IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues [J].
Gurney, AL .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2004, 4 (05) :669-677
[13]   Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae [J].
Happel, KI ;
Dubin, PJ ;
Zheng, MQ ;
Ghilardi, N ;
Lockhart, C ;
Quinton, LJ ;
Odden, AR ;
Shellito, JE ;
Bagby, GJ ;
Nelson, S ;
Kolls, JK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (06) :761-769
[14]  
IOVANNA J, 1991, J BIOL CHEM, V266, P24664
[15]   Discovery and biology of IL-23 and IL-27: Related but functionally distinct regulators of inflammation [J].
Kastelein, Robert A. ;
Hunter, Christopher A. ;
Cua, Daniel J. .
ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 :221-242
[16]   Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation [J].
Kebir, Hania ;
Kreymborg, Katharina ;
Ifergan, Igal ;
Dodelet-Devillers, Aurore ;
Cayrol, Romain ;
Bernard, Monique ;
Giuliani, Fabrizio ;
Arbour, Nathalie ;
Becher, Burkhard ;
Prat, Alexandre .
NATURE MEDICINE, 2007, 13 (10) :1173-1175
[17]   Activation of RegIIIβ/γ and interferon γ expression in the intestinal tract of SCID mice:: an innate response to bacterial colonisation of the gut [J].
Keilbaugh, SA ;
Shin, ME ;
Banchereau, RF ;
McVay, LD ;
Boyko, N ;
Artis, D ;
Cebra, JJ ;
Wu, GD .
GUT, 2005, 54 (05) :623-629
[18]   Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F [J].
Kuestner, Rolf E. ;
Taft, David W. ;
Haran, Aaron ;
Brandt, Cameron S. ;
Brender, Ty ;
Lum, Karen ;
Harder, Brandon ;
Okada, Shannon ;
Ostrander, Craig D. ;
Kreindler, James L. ;
Aujla, Shean J. ;
Reardon, Brian ;
Moore, Margaret ;
Shea, Pamela ;
Schreckhise, Randall ;
Bukowski, Thomas R. ;
Presnell, Scott ;
Guerra-Lewis, Patricia ;
Parrish-Novak, Julia ;
Ellsworth, Jeff L. ;
Jaspers, Stephen ;
Lewis, Katherine E. ;
Appleby, Mark ;
Kolls, Jay K. ;
Rixon, Mark ;
West, James W. ;
Gao, Zeren ;
Levin, Steven D. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (08) :5462-5473
[19]   Interleukin 22 is a candidate gene for Tmevp3, a locus controlling Theiler's virus-induced neurological diseases [J].
Levillayer, F. ;
Mas, M. ;
Levi-Acobas, F. ;
Brahic, M. ;
Bureau, J. F. .
GENETICS, 2007, 176 (03) :1835-1844
[20]   Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides [J].
Liang, Spencer C. ;
Tan, Xiang-Yang ;
Luxenberg, Deborah P. ;
Karim, Riyez ;
Dunussi-Joannopoulos, Kyriaki ;
Collins, Mary ;
Fouser, Lynette A. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (10) :2271-2279